Peripheral arterial disease (PAD) continues to grow in global prevalence and consumes an
increasing amount of resources in the United States health care system. Overall rates of …

Peripheral arterial disease (PAD) is a common manifestation of atherosclerosis that affects
more than 10 million people in the United States. The risk factors associated with PAD are …

Peripheral arterial disease (PAD) represents a spectrum from asymptomatic stenosis to limb-
threatening ischemia. The last decade has seen a tremendous increase in the variety of …

Effective revascularization of the patient with peripheral artery disease is about more than
the procedure. The approach to the patient with symptom-limiting intermittent claudication or …

The recommendations listed in this guideline are, whenever possible, evidence based. An
initial extensive evidence review, which included literature derived from research involving …

Peripheral artery disease (PAD), secondary to atherosclerotic disease, is currently the
leading cause of morbidity and mortality in the western world. While PAD is common, it is …

The original TransAtlantic InterSociety Consensus (TASC) on the Management of Peripheral
Arterial Disease (PAD) published in 2000 was the first international consensus on the …

Despite advances in medical therapies to help prevent the development of atherosclerosis
and improve the management of patients with established peripheral arterial disease (PAD) …

Whether symptomatic or not, peripheral arterial disease (PAD), atherosclerosis in the
arteries of the lower extremities, is a common disorder in the general population. The …

These guidelines address the diagnosis and management of atherosclerotic, aneurysmal,
and thromboembolic peripheral arterial diseases (PADs). The clinical manifestations of PAD …